US Dollar vs MXN

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

ADIL Adial Pharmaceuticals Inc

1.70

-0.09 (-5.03%)

03 May 2024 - Cerrado

Retrasado por 15 minutos

Form EFFECT - Notice of Effectiveness

Adial Pharmaceuticals (NASDAQ:ADIL)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Haga Click aquí para más Gráficas Adial Pharmaceuticals.

Adial Pharmaceuticals (NASDAQ:ADIL)
Gráfica de Acción Histórica
De May 2023 a May 2024

Haga Click aquí para más Gráficas Adial Pharmaceuticals.

Noticias sobre Adial Pharmaceuticals Inc ADIL

Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office
Lunes 22 de Abril 2024 (2 semanas hace) • GlobeNewswire Inc.

Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
Miércoles 10 de Abril 2024 (3 semanas hace) • GlobeNewswire Inc.

Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update
Martes 2 de Abril 2024 (1 mes hace) • GlobeNewswire Inc.

Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
Viernes 1 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office
Miércoles 28 de Febrero 2024 (2 meses hace) • GlobeNewswire Inc.

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Miércoles 14 de Febrero 2024 (3 meses hace) • Edgar (US Regulatory)

Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office
Martes 13 de Febrero 2024 (3 meses hace) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Jueves 25 de Enero 2024 (3 meses hace) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Miércoles 24 de Enero 2024 (3 meses hace) • Edgar (US Regulatory)

Form 8-K - Current report
Jueves 18 de Enero 2024 (4 meses hace) • Edgar (US Regulatory)

Adial Announces Appointment of Tony Goodman as Chief Operating Officer
Jueves 18 de Enero 2024 (4 meses hace) • GlobeNewswire Inc.

Form 8-K - Current report
Martes 16 de Enero 2024 (4 meses hace) • Edgar (US Regulatory)

Más de Adial Pharmaceuticals Inc Artículos de Noticias

Health Care Select Sector

Energy Select Sector SPDR

Deutsche Telekom (QX)

Bank of America

Invesco QQQ Trust Series 1

Financial Select Sector

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones